Indian Pharma Market Top 50 Ranking - June 2014 by AIOCD Pharmasofttech AWACS

128,803 views

Published on

Highlights of performance of Top 50 companies for the Month June 2014

Published in: Business, Technology

Indian Pharma Market Top 50 Ranking - June 2014 by AIOCD Pharmasofttech AWACS

  1. 1. Val in Crs MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% COMPANY MAT MTH 77529 100 6.7 6636 100 10.4 IPM 1 1 4218 5.44 15.8 349 5.26 16.1 Sun Pharma 1 1 2 2 3838 4.95 6.2 315 4.74 11.7 Cipla 2 2 3 3 3082 3.97 5.7 258 3.89 7.2 Zydus Cadila 4 3 4 5 3060 3.95 2.1 242 3.65 4.1 Ranbaxy 3 4 5 4 2759 3.56 5.7 246 3.71 14.8 Mankind 8 8 6 8 2697 3.48 -1.1 220 3.31 -1.1 Abbott HC 6 7 7 7 2694 3.47 -15.5 226 3.41 -7.0 Glaxo 5 6 8 6 2621 3.38 12.7 231 3.49 20.6 Lupin 7 5 9 9 2403 3.10 9.1 207 3.13 8.0 Alkem 9 9 10 11 2244 2.89 3.2 185 2.79 4.8 Pfizer 10 12 11 10 2102 2.71 13.3 200 3.01 29.5 Macleods 11 10 12 12 1975 2.55 14.1 185 2.79 26.6 Intas 12 11 13 13 1942 2.51 0.6 172 2.59 7.7 Sanofi-India 13 13 14 14 1902 2.45 14.7 170 2.56 17.1 Aristo 15 15 15 15 1724 2.22 2.7 156 2.34 12.0 Torrent 14 14 16 18 1688 2.18 16.7 136 2.05 16.9 Glenmark 16 17 17 16 1658 2.14 7.2 147 2.22 17.4 Dr. Reddys 17 16 18 17 1560 2.01 10.6 137 2.07 15.6 Micro Lab 19 19 19 19 1528 1.97 8.4 132 1.99 13.5 Abbott 18 18 20 22 1410 1.82 8.5 115 1.74 3.6 USV 20 22 21 20 1400 1.81 21.5 123 1.86 28.6 Ipca 21 20 22 21 1345 1.73 22.0 118 1.78 23.8 Emcure 22 21 23 23 1230 1.59 4.7 98 1.48 8.7 Wockhardt 23 23 24 24 1131 1.46 -1.5 93 1.40 -2.6 Novartis 24 24 25 25 1064 1.37 10.2 85 1.28 9.1 Alembic 25 25 26 27 831 1.07 3.9 66 0.99 -9.8 Zuventus 27 28 27 26 821 1.06 3.6 71 1.07 15.1 FDC 26 26 28 28 799 1.03 8.9 64 0.97 9.4 Unichem 28 27 29 29 686 0.89 14.7 61 0.93 7.3 Novo Nordisk 29 29 30 30 613 0.79 10.0 54 0.81 3.5 Cadila 30 30 31 32 599 0.77 7.1 51 0.76 12.8 Indoco Remedies 32 33 32 31 575 0.74 12.3 52 0.78 17.4 Franco 33 31 33 33 570 0.74 22.5 50 0.75 8.9 Eris 31 32 34 36 500 0.64 15.8 41 0.61 8.6 MSD 34 35 35 34 477 0.62 5.4 43 0.64 19.4 Himalaya 35 34 36 35 470 0.61 10.4 41 0.62 12.2 Merck 36 36 37 39 428 0.55 2.5 35 0.53 14.9 Blue Cross 38 41 38 37 412 0.53 11.4 39 0.58 19.5 JB Chemicals 37 37 39 45 392 0.51 13.6 29 0.43 -7.6 Astrazeneca 39 46 40 38 378 0.49 -0.2 37 0.55 7.9 Raptakos, Brett 40 38 41 41 378 0.49 -12.7 34 0.51 -13.2 Bharat Serums 41 40 42 40 378 0.49 23.7 34 0.52 21.5 Meyer Organics 42 39 43 51 349 0.45 11.6 27 0.40 10.3 Hetero 47 55 44 43 342 0.44 14.4 33 0.49 16.9 Medley 45 43 45 47 332 0.43 9.4 29 0.43 12.3 Janssen 43 45 46 44 331 0.43 9.8 31 0.47 14.7 Wallace 49 44 With Bonus Units at Full Value Witho Rank MAT June-14 Jun-14 Rank
  2. 2. 47 49 331 0.43 1.1 28 0.42 5.2 Win-Medicare 44 49 48 42 330 0.43 36.8 33 0.49 52.6 Akumentis 46 42 49 58 321 0.41 8.9 23 0.34 8.9 Fourrts 50 58 50 46 311 0.40 2.6 29 0.43 0.1 Albert David 48 48
  3. 3. Val (Cr) MS% GR% Val (Cr) MS% GR% 74585 100 6.8 6395 100 10.9 4123 5.53 14.9 343 5.36 16.4 3605 4.83 9.1 296 4.63 13.9 2893 3.88 5.6 242 3.79 6.5 2960 3.97 2.1 234 3.67 4.2 2339 3.14 7.4 212 3.31 18.5 2612 3.50 -1.5 213 3.34 -0.5 2663 3.57 -14.7 224 3.51 -5.6 2564 3.44 12.6 227 3.55 21.2 2237 3.00 9.3 194 3.04 9.8 2193 2.94 3.5 182 2.84 5.3 1970 2.64 13.0 187 2.93 29.5 1951 2.62 13.6 183 2.86 26.8 1907 2.56 0.4 168 2.63 8.1 1674 2.24 12.0 148 2.32 15.3 1689 2.26 3.0 152 2.38 12.1 1639 2.20 16.3 132 2.06 16.3 1624 2.18 6.3 144 2.26 17.1 1490 2.00 11.2 131 2.05 15.8 1517 2.03 8.0 131 2.05 13.6 1404 1.88 8.4 115 1.80 3.7 1332 1.79 21.4 118 1.85 30.2 1318 1.77 22.2 116 1.81 23.9 1206 1.62 4.5 97 1.51 9.3 1092 1.46 -0.8 90 1.41 -1.3 1032 1.38 10.8 83 1.30 10.3 793 1.06 4.2 63 0.98 -9.7 798 1.07 3.4 69 1.08 14.2 782 1.05 8.2 63 0.99 9.3 685 0.92 14.6 61 0.96 7.1 591 0.79 9.9 52 0.81 3.5 561 0.75 7.3 47 0.74 12.7 554 0.74 11.7 50 0.78 17.2 567 0.76 22.3 49 0.77 8.9 498 0.67 15.4 40 0.63 7.7 475 0.64 5.0 43 0.67 19.8 458 0.61 9.0 40 0.63 11.1 393 0.53 4.2 33 0.51 14.7 396 0.53 11.3 37 0.58 19.7 387 0.52 12.8 28 0.44 -7.5 373 0.50 -0.4 36 0.57 8.0 371 0.50 -13.1 33 0.52 -12.8 366 0.49 23.6 33 0.52 21.9 318 0.43 12.0 24 0.38 10.7 325 0.44 15.1 31 0.49 16.9 332 0.44 9.4 28 0.45 12.3 305 0.41 15.5 30 0.48 27.6 Without Bonus Units MAT June-14 Jun-14
  4. 4. 326 0.44 -0.3 27 0.43 3.4 324 0.43 38.6 32 0.50 53.0 304 0.41 7.9 22 0.34 8.4 305 0.41 2.6 28 0.44 -0.1

×